コンテンツへスキップ
Merck
  • Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies.

Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies.

The British journal of nutrition (2013-11-28)
Youjin Je, Edward Giovannucci
要旨

Coffee consumption has been shown to be associated with various health outcomes, but no comprehensive review and meta-analysis of the association between coffee consumption and total mortality has been conducted. To quantitatively assess this association, we conducted a meta-analysis of prospective cohort studies. Eligible studies were identified by searching the PubMed and EMBASE databases for all articles published through June 2013 and reviewing the reference lists of the retrieved articles. Pooled relative risks (RR) with 95% CI were calculated using a random-effects model. We identified twenty studies of coffee consumption and total mortality, including 129,538 cases of deaths among the 973,904 participants. The RR of total mortality for the high v. low category of coffee consumption was 0.86 (95% CI 0.80, 0.92). The pooled RR for studies using ≥ 2-4 cups/d as a cut-off for the high category was similar to that for studies using ≥ 5-9 cups/d as the cut-off. By geographical region, the inverse association tended to be stronger for the eight studies conducted in Europe (RR 0.78, 95% CI 0.70, 0.88) and three studies carried out in Japan (RR 0.82, 95% CI 0.73, 0.92) than for the nine studies conducted in the USA (RR 0.92, 95% CI 0.84, 1.00). The inverse association was similar for men (RR 0.81, 95% CI 0.73, 0.90) and women (RR 0.84, 95% CI 0.79, 0.89). A weak, but significant, inverse association was found with moderate coffee consumption (1-2 cups/d; RR 0.92, 95% CI 0.87, 0.98). High decaffeinated coffee consumption was also found to be associated with a lower risk of death, but the data are limited. Our findings indicate that coffee consumption is associated with a reduced risk of total mortality.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
カフェイン, anhydrous, 99%, FCC, FG
USP
カフェイン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
カフェイン, powder, ReagentPlus®
Supelco
カフェイン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
カフェイン融点標準品, United States Pharmacopeia (USP) Reference Standard
Supelco
カフェイン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
カフェイン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
カフェイン, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
カフェイン, Sigma Reference Standard, vial of 250 mg
Supelco
融点スタンダード235~237°C, analytical standard
Supelco
カフェイン 溶液, analytical standard, 1.0 mg/mL in methanol
Supelco
Mettler-Toledo®キャリブレーション用物質ME 18872、カフェイン, traceable to primary standards (LGC)
Sigma-Aldrich
カフェイン, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
カフェイン, SAJ special grade, ≥98.5%
Sigma-Aldrich
カフェイン, meets USP testing specifications, anhydrous
Sigma-Aldrich
カフェイン, BioXtra
システム適合性用カフェイン, European Pharmacopoeia (EP) Reference Standard
カフェイン, European Pharmacopoeia (EP) Reference Standard